NCT01051557 2021-07-19Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaNational Cancer Institute (NCI)Phase 1/2 Completed36 enrolled 15 charts
NCT00058214 2015-02-23Perifosine in Treating Patients With Recurrent Prostate CancerNational Cancer Institute (NCI)Phase 2 Terminated25 enrolled 5 charts